Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Gains from Investment Securities (2017 - 2025)

Serina Therapeutics (SER) has disclosed Gains from Investment Securities for 9 consecutive years, with -$3.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 131.0% to -$3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.3 million through Dec 2025, down 124.53% year-over-year, with the annual reading at -$4.3 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities hit -$3.2 million in Q4 2025 for Serina Therapeutics, down from -$1.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.4 million in Q4 2024 to a low of -$6.7 million in Q3 2024.
  • Historically, Gains from Investment Securities has averaged $86424.1 across 5 years, with a median of -$6500.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: crashed 1602.86% in 2023 and later skyrocketed 57877.78% in 2024.
  • Year by year, Gains from Investment Securities stood at $96000.0 in 2021, then crashed by 94.79% to $5000.0 in 2022, then plummeted by 460.0% to -$18000.0 in 2023, then surged by 57877.78% to $10.4 million in 2024, then crashed by 131.0% to -$3.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for SER at -$3.2 million in Q4 2025, -$1.0 million in Q3 2025, and $1.0 million in Q2 2025.